Immuron (IMRN) Gross Profit (2016 - 2024)
Immuron (IMRN) posted Gross Profit of $22234.2 for Q3 2024, down 97.39% on a QoQ basis from $852242.2 in Q4 2023.
Analysis
Immuron (IMRN) Gross Profit (2016 - 2024) Analysis & Trends
Immuron has reported Gross Profit for 9 years, with the latest figure at $22234.2 in Q3 2024.
- On a quarterly basis, Gross Profit changed N/A year-over-year to $22234.2 in Q3 2024; TTM through Sep 2024 was $1.4 million, a N/A change from a year earlier, with the FY2026 full-year figure at $5.0 million, up 10340.65% from the prior year.
- Gross Profit was $22234.2 for Q3 2024 at Immuron, down from $852242.2 in the prior quarter.
- The five-year high for Gross Profit was $852242.2 in Q4 2023, with the low at $57.2 in Q4 2020.
- Average Gross Profit over 5 years is $228711.2, with a median of $45432.8 recorded in 2023.
- The sharpest annual moves came in 2020 and 2022: Gross Profit sank 99.49% in 2020, then soared 36086.56% in 2022.
- Over 5 years, Gross Profit stood at $57.2 in 2020, then soared by 1967.53% to $1182.5 in 2021, then jumped by 36086.56% to $427920.0 in 2022, then surged by 99.16% to $852242.2 in 2023, then slumped by 97.39% to $22234.2 in 2024.
- The last three Gross Profit figures came in at $22234.2 (Q3 2024), $852242.2 (Q4 2023), and $68631.3 (Q2 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn |
| 10 | Immuron | 7.14 Mn | -1.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 9, 2024 | 22,234.25 |
| Dec 31, 2023 | 852,242.23 |
| Jun 30, 2023 | 68,631.26 |
| Dec 31, 2022 | 427,920.00 |
| Dec 31, 2021 | 1,182.54 |
| Dec 31, 2020 | 57.20 |
| Dec 31, 2019 | 11,214.25 |
| Dec 31, 2018 | 746,754.00 |
| Dec 31, 2017 | 556,616.27 |
| Dec 31, 2016 | 361,687.03 |
| Jun 30, 2016 | 637,749.57 |